Stockhub

Acadia Pharmaceuticals English (Q4671580)

Item Discussion
Pharmaceutical company, which developed Nuplazid, based in San Diego, California. English
edit
Language Label Description Also known as
British English
No label defined
No description defined

    Statements

    instance of
    business
    0 references
    public company
    0 references
    stock exchange
    NASDAQ
    ticker symbol
    ACAD
    start time
    27 Mayıs 2004
    2 references
    imported from Wikimedia project
    English Wikipedia
    stated in
    Q105523379 (Deleted Item)
    named as
    ACADIA Pharmaceuticals Inc.
    retrieved
    26 February 2021
    industry
    Q507443 (Deleted Item)
    0 references
    ISNI
    0000 0004 0407 8796
    1 reference
    DOI
    10.6084/M9.FIGSHARE.4539889
    Ringgold ID
    17425
    1 reference
    stated in
    Q64159407 (Deleted Item)
    GRID ID
    grid.417646.6
    2 references
    stated in
    Q53705075 (Deleted Item)
    stated in
    Q53705036 (Deleted Item)
    Microsoft Academic ID
    125377440
    1 reference
    stated in
    Q60683589 (Deleted Item)
    GRID ID
    grid.417646.6
    retrieved
    19 Ocak 2019
    ROR ID
    030bhbq32
    0 references
    Twitter username
    acadiapharma
    Twitter user numeric ID
    3313753544
    start time
    12 August 2015
    point in time
    30 December 2020
    1 reference
    stated in
    Q648625 (Deleted Item)
    retrieved
    4 October 2020
    Freebase ID
    /m/03p1cpg
    Freebase ID
    /m/03p1cpg
    1 reference
    stated in
    Q648625 (Deleted Item)
    retrieved
    4 October 2020
    Central Index Key English
    0001070494
    1 reference
    stated in
    Q105523379 (Deleted Item)
    named as
    ACADIA Pharmaceuticals Inc.
    retrieved
    26 February 2021
    Crossref funder ID
    100014387
    0 references
     
    Retrieved from ‘https://stockhub.co/index.php?title=Item:Q4671580&oldid=109279’